Tracy Byerly, MD
Otolaryngology · Fredericksburg, TXNPI 1427354208
Payments from drug & device makers
Across 218 payments — averaging $98.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Aerin Medical Inc.$5K
- Stryker$3K
- Intersect ENT, Inc.$2K
- Inspire Medical Systems, Inc.$662
- Neurent Medical Limited$426
- plus $3K from 23 others
Across 19 payments — averaging $3572.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$34K
- Arrinex, Inc.$26K
- Aerin Medical Inc.$8K
What the payments were for
- Consulting fees$2,90015%
- Speaking & faculty fees$6,41734%
- Travel & lodging$7384%
- Food & beverage$8,87747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $8,192 |
| Aerin Medical Inc. | 33 | $5,417 |
| Stryker | 25 | $2,526 |
| Intersect ENT, Inc. | 17 | $1,686 |
| Inspire Medical Systems, Inc. | 23 | $662 |
| Neurent Medical Limited | 10 | $426 |
| Sanofi | 20 | $420 |
| Preceptis Medical, Inc. | 1 | $378 |
| GSK | 20 | $369 |
| Sanara Medtech Inc. | 2 | $294 |
| Acclarent, Inc | 5 | $204 |
| Innovation Technologies Inc | 1 | $129 |
| AstraZeneca | 7 | $119 |
| Alk-abello, Inc | 5 | $111 |
| Spirair, Inc. | 1 | $94 |
| Sanofi-aventis U.S. LLC | 5 | $92 |
| Olympus America Inc. | 4 | $84 |
| Optinose US, Inc. | 4 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $49 |
| Integra Lifesciences Corporation | 1 | $45 |
| Arrinex, Inc. | 1 | $27 |
| AbbVie | 1 | $25 |
| Pharming Healthcare, Inc. | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Kaleo, Inc. | 1 | $20 |
| Xoran Technologies LLC | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PTEYE PARATHYROID DETECTION SYSTEM$6,998
- RHINAER STYLUS$1,900
- VIVAER STYLUS$1,400
- PROPEL$1,308
- Hummingbird Tympanostomy Tube System$378
- ENTELLUS - XPRESS ENT DILATION SYSTEM$371
- SINUVA$368
- Inspire Upper Airway Stimulation System$307
- CellerateRx$294
- NUVENT$262
- NEUROMARK Device$177
- NEUROMARK Radiofrequency Generator$177
- NAV - CRANIALMAP NUERO SOFTWARE AND INSTRUMENTATION$150
- CLARIFIX CRYOTHERAPY DEVICE$150
- Irrisept$129
- TruDi Navigation System$104
How this compares
$21,532 in reported general payments places this provider in the 90th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Flucytosine | 26 | $61,764 |
| Epinephrine | 18 | $4,123 |
| Azelastine Hcl | 102 | $3,012 |
| Fluticasone Propionate | 100 | $1,902 |
| Ofloxacin | 60 | $1,302 |
| Ipratropium Bromide | 32 | $1,158 |
| Cefdinir | 49 | $1,023 |
| Montelukast Sodium | 74 | $977 |
| Mupirocin | 56 | $954 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 64 | $679 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 69 | $578 |
| Levocetirizine Dihydrochloride | 29 | $448 |
| Levothyroxine Sodium | 49 | $436 |
| Gabapentin | 51 | $287 |
| Cephalexin | 92 | $282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $17 | $4,12318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 729 otolaryngology providers in Texas.
Other otolaryngology in Fredericksburg
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
- Amber LuongHouston$793K
- Jeffrey RosenbloomSan Antonio$720K
- Masayoshi TakashimaHouston$644K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.